Pharmaceuticals
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the Phase III JAVELIN Bladder 100 study online ahead of print inThe New England Journal of...
2020-09-18 15:00
4539
First patient in treatment in RhoVac's clinical phase IIb study in Sweden
STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onSeptember 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in Sweden is enrolled in the cli...
2020-09-17 23:51
1978
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma"), a Viva Biotech Portfolio Company, has reached an agreement for the acquisition of its oral PCSK9 program by AstraZeneca. Dogma will receive upfront as well as downstream payments linked to global regulatory and commerc...
2020-09-17 20:25
2043
Alter Pharma Group Adopts Movilitas.Cloud to Ensure Safer Goods and EU FMD Compliance Throughout the Product Path and Changes in Packaging
Solution supports requirements for traceability down to the single package level and optimizes the repackaging process for increased efficiency and safer medicine COLUMBIA, Maryland, Sept. 16, 2020 /PRNewswire/ -- Movilitas announced that the Alter Pharma Group, a pharmaceutical group active in ...
2020-09-16 21:39
1733
Sanofi partners with Health2Sync to deliver an innovative digital solution to patients and healthcare providers, paving the way for digital therapeutics in diabetes
* Starting in Taiwan, this partnership aims to on-board clinics and hospitals nationwide over the next 3 years * Health2Sync to provide patient management software, patient app, and analytics to facilitate smart insulin management * Bi-lateral digital touchpoints empower patients with person...
2020-09-16 19:12
776
CIRT-EU Registry for SIR-Spheres(R) Therapy presented at CIRSE 2020 Summit
Largest European-wide observational, multicenter registry of SIR-Spheres Y-90 resin microspheres for liver tumors conducted by CIRSE reports safety and survival data WOBURN, Mass., Sept. 15, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies...
2020-09-15 20:00
1455
Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction
HONG KONG, Sept. 15, 2020 /PRNewswire/ -- Recently, share price of Sihuan Pharmaceutical (0460.HK) continued to rise, hittingHK$1.09 per share, up 53.52% from its low onMay 25. Judging from the stock price trend, the stock price of Sihuan Pharmaceutical seems to have entered the stage of reboundi...
2020-09-15 18:05
4238
Elekta introduces new radiotherapy solution to help address worldwide cancer burden
- Elekta Harmony to shorten treatment times and reduce footprint while maintaining high precision STOCKHOLM, Sept. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced its Elekta Harmony* linear accelerator (linac), a cancer treatment system designed to meet healthcare centers' need for ...
2020-09-15 18:03
8516
MAGHREB PHARMA Expo to contribute to Algeria plans to export for US$ 5 billion locally produced drugs by 2025
ALGIERS, Algeria, Sept. 15, 2020 /PRNewswire/ --Easyfairs Northeral, the organizer of MAGHREB PHARMA Expo has announced new dates for its annual international tradeshow for the pharmaceutical industry inNorth Africa. In this context, the Algerian Pharmaceutical Industry Minister,Lotfi Benbahmed, ...
2020-09-15 14:00
1444
Standigm Partners with Excelra for GOSTAR to Enhance its AI-driven Drug Discovery Process
HYDERABAD, India and SEOUL, South Korea, Sept. 15, 2020 /PRNewswire/ -- Excelra
2020-09-15 10:00
1571
Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-09-15 03:41
1584
TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury ...
2020-09-14 20:35
1357
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Granted Orphan Drug Designation by the FDA for the Treatment of Gastric Cancer
SUZHOU, China and ROCKVILLE, Md., Sept. 14, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug ...
2020-09-14 18:35
690
Countering counterfeit medicines in the fast-paced world of e-commerce
BANGKOK, Sept. 14, 2020 /PRNewswire/ -- Research shows that counterfeit medicine cannot cure illnesses and can cause moreharm to your health. Counterfeit medicines have been in the market for a long time, and without sufficient awareness, consumption of these substances can lead to unexpected sy...
2020-09-14 16:59
1434
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer * Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib† from largest ongoing st...
2020-09-14 10:41
1664
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...
2020-09-14 08:30
1924
Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...
2020-09-14 08:17
2271
SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia
Phase 3 clinical trial to support registrational filings in China and Japan Company on track to expand presence in Asia, reflecting its commitment to reach more people with epilepsy worldwide PANGYO, GYEONGGI PROVINCE, Korea, Sept. 12, 2020 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a glo...
2020-09-12 03:13
4636
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...
2020-09-11 20:00
4675
Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA
CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ -- Sai Life
Sciences, one ofIndia's fastest growing Contract Development & Manufacturing
Organizations (CDMOs)
2020-09-11 11:30
2647
Week's Top Stories
Most Reposted
Suncity Group Recognized as "Honored Company" by Institutional Investor
[Picked up by 121 media titles]
2020-09-16 18:05
ASTRI and the University of Hong Kong to nurture FinTech talent of the future
[Picked up by 119 media titles]
2020-09-15 12:01
Huawei Showcases Key Milestones Achieved with its Local Partners During Huawei Developer Conference 2020
[Picked up by 118 media titles]
2020-09-14 10:08
"A Dialogue with the 5,000-Year-Old Liangzhu Culture" global creative short video contest opens for registration
[Picked up by 116 media titles]
2020-09-16 10:45
Senior Investment Banker Joins PropTech Co-Investment Firm - RealVantage
[Picked up by 115 media titles]
2020-09-14 17:31
Most Read
Johnson Controls Officially Opens its S$50 million Innovation Center in NUS
2020-09-17 14:25
21220
Infosys to Acquire GuideVision, a Leading ServiceNow Elite Partner in Europe
2020-09-14 14:16
15889